Tnmakingitrain

Artificial intelligence growth 450% AND Healthcare growth 53% for 2025. 0 Debt Plenty of Cash, Full Year Profitablty for 2026. Management owns more then 20% of $CLOV $MFST $ARK $BRKA $GOOGL $NVDA $TSLA $META $AAPL $TSM $AMZN $SAP $CRM $PLTR $ORCL $JPM $BAC $BRKB $AVGO $AMD $ORCL

@ManzTrades @jukan05 Wow it went from 455 to 458

@jukan05 Boomin

Axios: Microsoft is expected to unveil new software that allows users to have AI agents perform tasks locally on Windows PCs. $NVDA $MSFT

@J_Pugh_13 @BainCapital @CloverHealth A drop in the bucket, 20% of CLOV for less then 500million. At today's stock price

@BainCapital @CloverHealth Bain Capital currently has $225B in AUM. 🤯 They obviously see the future and potential in @CloverHealth $CLOV

In a recent episode of The Future of Healthcare AI, we speak with Andrew Toy, CEO of @CloverHealth, a Medicare Advantage insurer serving over 150,000 members that is rethinking what it means to be an AI-native payer. His argument is straightforward: you can change outcomes without waiting for new science by identifying disease early enough and treating it with existing therapeutics. Andrew also makes a compelling case for why holding the risk changes everything. When a payer is genuinely accountable for outcomes, the incentive to keep people healthier longer stops being philosophical and starts being structural. Listen to the full conversation on our Healthcare site: bit.ly/4unh3xn #HealthcareAI

@4MileRunCapital You believe CLOV is worth 3.5 Billion instead of 2.1 Billion.

$CLOV Even if you assume the worst case scenario where the rating remains unchanged, lower end of the profit target for 2026 (breakeven) only 5% growth and outstand shares increasing due to unforeseen dilution event, no news on Counterpart, you are still looking at a $6 - $7 if you hold for a year. This stock has turned a corner. Know what you own and why you own it!

$clov CLOV we expect a decision on 2027 star Rating before the end of june 2026

@AlbertAlan @ALSTOCKTRADES ANYONE, I understand star Rating is a year behind, are we not fighting for 2027 3.5star rating to be 4stars in 2027. And not 2026

$CLOV I just bought the whole legal document. We'll be doing a LIVE soon! "A judge told officials to redo Clover's 2026 rating after partly agreeing with Clover and rejecting the other side."

@TheBeckford Payout on star ratings are a year behind. 2026 4 stars are based on October 2024 ratings. The 4 stars your talking about is from October 2025 Payout for 2027. Not 2026

The $120 Million Catalyst the Market is Ignoring: A Deep Dive into Clover Insurance Co. v. CMS $CLOV

@AlbertAlan It could be just to count the money they pay Doctors to use it, they did pay $45 every time it was used 2 years ago. They have took that cost down since, we investors noticed it and posted it. Look both ways when Clover post something

$CLOV HUGE! Director, Strategic Finance (Counterpart Health) Shout out to PalmJr57!

@anothercohen Late to the AI Healthcare game , jeopardy: what is $CLOV

So excited to be a tiny investor in Kin Health which is building a personal AI care navigator. Strongly believe that in a couple of years, every single person will have an AI that listens to their doctors visits and helps manage all of their care, from simple urgent care visits to complex chronic conditions and surgeries.

@Task_Master_17 That's alot of money, how much would he have if he sold all his shares? Part 2 question is he going to be a seller every 30% raise

$CLOV Peter Kuipers - selling $3,000,000 bucks worth. sec.gov/Archives/edgar…

$CLOV $HUM

@Impervious38 Hiring and good signs everywhere, thank you again

Hiring velocity has been off the charts lately, so I truly believe things are moving very fast now. However, Healthcare on the whole moves slow, hence here we are two years after Counterpart Health was announced. The market is sleeping on this story and no one knows when they will catch on. Once financial metrics are broken out specifically for CH then they won't have any choice but acknowledge what's happening. Could be this year or next imo.

If Counterpart Health succeeds, $CLOV won’t be valued like a payer. Because what’s being built follows an 8-stage evolution that ends in platform dominance. Here’s how it unfolds 👇

@Impervious38 First thank you, I been in clov since the 2021 June pop and bust, what's your Time-line for Market Makers. I get MA in 7 years. My dad will be died before getting back to $15 a share, he is 81. All my fault for truly Dumb money. Thank you for not giving up, and helping us.

✅ Proofpoints: 1. TEFCA-native, real-time data ubiquity 2. Required or default integration layer 3. International expansion or federal alignment

@CloverHealth @GhostOfLaszloJ @TheWebbyAwards Wow a CEO bought shares not $$$ amount

Healthcare AI just showed up at the Webbys. 🏆 The Clover Health Broker Assistant is a 2026 @TheWebbyAwards nominee in AI – Customer Experience or CRM. We built it to take the complexity out of Medicare Advantage for the brokers on the front lines helping people find the right plan for them. Voting is open through April 16, every vote counts and we'd appreciate your support. 👉 wbby.co/58831N

@GunShow_Trader I suppose milestones of achievement is no longer in play. Golden Parachute for everyone

$CLOV SEC Filing | Clover Health | $CLOV More fucking free shares: - Karen gets about 1.5 million shares. This is 25% of those. - Conrad gets 1.1 million shares. This is 25% of those. More investor money pissed away for not hitting higher share price goals. Zero ROI for investors & they’re being rewarded. For what?? investors.cloverhealth.com/node/12261/html investors.cloverhealth.com/node/12266/html

@jessupgoeslong @GunShow_Trader @VivekGaripalli I remember Vivek being more actively speaking about $CLOV on Twitter and LinkedIn other then regular conference and etc. Toy NEVER say anything other then what we see. Vivek with his 90,000,000 share investment was always speaking CLOV. Toy which 1/10 stock holding, no buys, mis

@GunShow_Trader @VivekGaripalli Was Vivek any good as a CEO? Why’d he step aside? Idk if the optics would look great w this…

$CLOV - IF Andrew steps back into CTO role and @VivekGaripalli steps back in as CEO, I called it. You look goofy if you believe otherwise.

@defense_civil25 Take lies down or get blocked

🚨Update: Iran destroyed a commercial vessel, sailing under the flag of the Marshall Islands, attempting to pass through the Strait of Hormuz. Iran said the strait is closed except for their allies!

@RapallaInvests Still here, appreciate all content. Investors will come in glad and leave happy or sad. Hopefully one day or year we get the gold

Update: Many of you have noticed that I have been reluctant to post much research or even reactions to Clover news the last 6-8 weeks. This has been a culmination of several factors that I will briefly list below: -Started a new job/got promoted which has taken up more of my time and energy -Retail sentiment has become so low that a lot of the feedback on posts is negative/unreasonable at times (in my opinion of course) -Findings of value that I’d consider worth posting have been non-existent A moment of transparency: I never created this account with the intent to “pump” the stock price as I have been called out for many times in the last couple months. I understand and recognize that at times I posted things with excess excitement, but I am being genuine when I say my thought process was not rooted in “let’s drive sentiment up so the price moves” - I was simply excited to share new information on a stock I am quite literally all in on and have been all in on for years. The research, the discussions, the feedback, it was always the thrill of the chase and learning something new everyday and sharing that experience with people I’ve grown to call friends. I’ve found community with $CLOV holders. For me it was joy to share info and be apart of something like this community. With that being said, I no longer feel that it is good for my mental health to be active and tweet here. I remain and shall continue to be a shareholder in $CLOV. I’ve already unofficially been gone from this account but I feel it is necessary to put a formal end to it, maybe temporarily, maybe forever. I’ve made and lost friends in this community but in the end I only wish the best for us all. I believe the best is yet to come! Now it is time to focus elsewhere. Until next time

@derekquick1 I love going to outdated equipment facilities by UNH, this Is better Artificial intelligence then their Optuim that target my benefits then when they find something deny my Claims. Better MCR for sure.

$UNH UnitedHealth Group just quietly dropped another major catalyst that the market is not pricing in yet. “Avery,” a generative AI companion now rolling out across millions of members, with plans to scale to 20M users this year. MCR% is really going to drop a lot and this years MA% with coding upwards of 7% will make earnings beat every quarter. -Avery will reduce administrative friction across claims, scheduling, benefits navigation -90% of interactions don’t require a human advocate boosting savings -Guides patients to lower-cost, in-network care which will improve MCR % over time - It enhances member experience leading to retention & pricing power - Feeds off billions of data points never used before compounding AI advantage. Healthcare was always the major sector that will increase margins the most as AI is introduced and is exactly the type of internal efficiency & cost control lever that drives margin expansion in healthcare. You will start to see it on next months earnings, you were warned ;)